<!doctype html><html lang=en dir=auto><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><meta name=robots content="index, follow"><title>Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine | Roudranil</title><meta name=keywords content><meta name=description content="Synopsis 2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom."><meta name=author content="Roudranil"><link rel=canonical href=https://roudranil.github.io/projects/dissertation/><link crossorigin=anonymous href=/assets/css/stylesheet.css rel="preload stylesheet" as=style><script defer crossorigin=anonymous src=/assets/js/highlight.js onload=hljs.initHighlightingOnLoad()></script>
<link rel=icon href=https://roudranil.github.io/favicon.ico><link rel=icon type=image/png sizes=16x16 href=https://roudranil.github.io/favicon-16x16.png><link rel=icon type=image/png sizes=32x32 href=https://roudranil.github.io/favicon-32x32.png><link rel=apple-touch-icon href=https://roudranil.github.io/apple-touch-icon.png><link rel=mask-icon href=https://roudranil.github.io/safari-pinned-tab.svg><meta name=theme-color content="#2e2e33"><meta name=msapplication-TileColor content="#2e2e33"><noscript><style>#theme-toggle,.top-link{display:none}</style></noscript><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.12.0/dist/katex.min.css integrity=sha384-AfEj0r4/OFrOo5t7NnNe46zW/tFgW6x/bCJG8FqQCEo3+Aro6EYUG4+cU+KJWu/X crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.12.0/dist/katex.min.js integrity=sha384-g7c+Jr9ZivxKLnZTDUhnkOnsh30B4H0rpLUpJ4jAIKs4fnJI+sEnkvrMWph2EDg4 crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.12.0/dist/contrib/auto-render.min.js integrity=sha384-mll67QQFJfxn0IYznZYonOWZ644AWYC+Pt2cHqMaRhXVrursRwvLnLaebdGIlYNa crossorigin=anonymous onload='renderMathInElement(document.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"\\[",right:"\\]",display:!0},{left:"$",right:"$",display:!1},{left:"\\(",right:"\\)",display:!1}]})'></script><meta property="og:title" content="Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine"><meta property="og:description" content="Synopsis 2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom."><meta property="og:type" content="article"><meta property="og:url" content="https://roudranil.github.io/projects/dissertation/"><meta property="article:section" content="projects"><meta property="article:published_time" content="2022-09-06T22:00:32+05:30"><meta property="article:modified_time" content="2022-09-09T22:03:46+05:30"><meta property="og:site_name" content="Roudranil"><meta name=twitter:card content="summary"><meta name=twitter:title content="Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine"><meta name=twitter:description content="Synopsis 2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom."><script type=application/ld+json>{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":2,"name":"Projects","item":"https://roudranil.github.io/projects/"},{"@type":"ListItem","position":3,"name":"Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine","item":"https://roudranil.github.io/projects/dissertation/"}]}</script><script type=application/ld+json>{"@context":"https://schema.org","@type":"BlogPosting","headline":"Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine","name":"Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine","description":"Synopsis 2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom.","keywords":[],"articleBody":"Synopsis 2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom. We use the Bayesian paradigm to model the posterior distribution of the vaccine efficacy and calculate its credible interval.\nMethods: In order to perform Bayesian inference, we impose prior distributions on the incidence rate of infection in the vaccine and the control cohorts. In another model we impose prior distributions of the parameters of the infection process in both cohorts. The likelihood of observed data is then chosen suitably, and the data is collected from “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK”, by Voysey et al. Vaccine efficacy is then modelled as a function of these parameters (i.e., either the incidence rates or parameters of infection processes). Using Bayes’ Theorem, we then compute the posterior densities of the parameters and vaccine efficacy consequently.\nResults: Using the posterior density of vaccine efficacy we can compute the predicted vaccine efficacy, and also the corresponding 95% Bayesian Credible Intervals. The values obtained by Bayesian methods are in excellent agreement with those obtained in the paper.\nConcluding remarks: From the results of our models, we can conclude that a Bayesian analysis of vaccine clinical trials data is also a viable method to compute the efficacy.\nLink to the paper The full text of the project paper is available here.\nThe code associated with the paper (as well as the paper itself) can be found in this repo.\n","wordCount":"324","inLanguage":"en","datePublished":"2022-09-06T22:00:32+05:30","dateModified":"2022-09-09T22:03:46+05:30","author":{"@type":"Person","name":"Roudranil"},"mainEntityOfPage":{"@type":"WebPage","@id":"https://roudranil.github.io/projects/dissertation/"},"publisher":{"@type":"Organization","name":"Roudranil","logo":{"@type":"ImageObject","url":"https://roudranil.github.io/favicon.ico"}}}</script></head><body class=dark id=top><script>localStorage.getItem("pref-theme")==="light"&&document.body.classList.remove("dark")</script><header class=header><nav class=nav><div class=logo><a href=https://roudranil.github.io accesskey=h title="Roudranil (Alt + H)">Roudranil</a><div class=logo-switches><button id=theme-toggle accesskey=t title="(Alt + T)"><svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/></svg><svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="5"/><line x1="12" y1="1" x2="12" y2="3"/><line x1="12" y1="21" x2="12" y2="23"/><line x1="4.22" y1="4.22" x2="5.64" y2="5.64"/><line x1="18.36" y1="18.36" x2="19.78" y2="19.78"/><line x1="1" y1="12" x2="3" y2="12"/><line x1="21" y1="12" x2="23" y2="12"/><line x1="4.22" y1="19.78" x2="5.64" y2="18.36"/><line x1="18.36" y1="5.64" x2="19.78" y2="4.22"/></svg></button></div></div><ul id=menu><li><a href=https://roudranil.github.io/about/ title=About><span>About</span></a></li><li><a href=https://roudranil.github.io/posts title=Posts><span>Posts</span></a></li><li><a href=https://roudranil.github.io/projects title=Projects><span>Projects</span></a></li><li><a href=https://roudranil.github.io/academics title=Academics><span>Academics</span></a></li><li><a href=https://roudranil.github.io/search/ title="Search (Alt + /)" accesskey=/><span>Search</span></a></li></ul></nav></header><main class=main><article class=post-single><header class=post-header><div class=breadcrumbs><a href=https://roudranil.github.io>Home</a>&nbsp;»&nbsp;<a href=https://roudranil.github.io/projects/>Projects</a></div><h1 class=post-title>Bayesian Analysis of Efficacy of the ChAd0x1 nCoV-19 (AZD1222) Vaccine</h1><div class=post-meta><span title='2022-09-06 22:00:32 +0530 +0530'>September 6, 2022</span>&nbsp;·&nbsp;2 min&nbsp;·&nbsp;Roudranil</div></header><div class=toc><details><summary accesskey=c title="(Alt + C)"><span class=details>Table of Contents</span></summary><div class=inner><nav id=TableOfContents><ul><li><a href=#synopsis>Synopsis</a></li><li><a href=#link-to-the-paper>Link to the paper</a></li></ul></nav></div></details></div><div style=text-align:justify class=post-content><h2 id=synopsis>Synopsis<a hidden class=anchor aria-hidden=true href=#synopsis>#</a></h2><p>2020 saw the onset of the onset of the Covid-19 pandemic cause by the SARS-CoV-2 virus. With the number of daily affected people and number of deaths due to the pandemic climbing sharply, a vaccine was the need of the hour. In this paper we consider one such vaccine, the ChAdOx1 nCoV-19 (AZD1222) vaccine (known as Covishield in India), and we investigate its efficacy based on studies of four randomised controlled trials held in Brazil, South Africa, and the United Kingdom. We use the Bayesian paradigm to model the posterior distribution of the vaccine efficacy and calculate its credible interval.</p><p><em>Methods</em>: In order to perform Bayesian inference, we impose prior distributions on the incidence rate of infection in the
vaccine and the control cohorts. In another model we impose prior distributions of the parameters of the infection process in both cohorts. The likelihood of observed data is then chosen suitably, and the data is collected from “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK”, by Voysey et al. Vaccine efficacy is then modelled as a function of these parameters (i.e., either the incidence rates or parameters of infection processes). Using Bayes’ Theorem, we then compute the posterior densities of the parameters and vaccine efficacy consequently.</p><p><em>Results</em>: Using the posterior density of vaccine efficacy we can compute the predicted vaccine efficacy, and also the
corresponding 95% Bayesian Credible Intervals. The values obtained by Bayesian methods are in excellent agreement with those obtained in the paper.</p><p><em>Concluding remarks</em>: From the results of our models, we can conclude that a Bayesian analysis of vaccine clinical trials
data is also a viable method to compute the efficacy.</p><h2 id=link-to-the-paper>Link to the paper<a hidden class=anchor aria-hidden=true href=#link-to-the-paper>#</a></h2><p>The full text of the project paper is <a href=/pdfs/dissertation.pdf>available here</a>.</p><p>The code associated with the paper (as well as the paper itself) can be found in this <a href=https://github.com/Roudranil/Bayesian-analysis-of-efficacy-of-the-ChAdOx1-nCoV-19-AZD1222-vaccine>repo</a>.</p></div><footer class=post-footer><ul class=post-tags></ul><nav class=paginav><a class=prev href=https://roudranil.github.io/projects/financial-literacy/><span class=title>« Prev</span><br><span>Financial Literacy among 18-35 year olds</span></a></nav></footer></article></main><footer class=footer><span>© 2022 Roudranil Das |</span>
<span>Powered by
<a href=https://gohugo.io/ rel="noopener noreferrer" target=_blank>Hugo</a> &
        <a href=https://github.com/adityatelange/hugo-PaperMod/ rel=noopener target=_blank>PaperMod</a></span></footer><a href=#top aria-label="go to top" title="Go to Top (Alt + G)" class=top-link id=top-link accesskey=g><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentcolor"><path d="M12 6H0l6-6z"/></svg></a><script>let menu=document.getElementById("menu");menu&&(menu.scrollLeft=localStorage.getItem("menu-scroll-position"),menu.onscroll=function(){localStorage.setItem("menu-scroll-position",menu.scrollLeft)}),document.querySelectorAll('a[href^="#"]').forEach(e=>{e.addEventListener("click",function(e){e.preventDefault();var t=this.getAttribute("href").substr(1);window.matchMedia("(prefers-reduced-motion: reduce)").matches?document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView():document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView({behavior:"smooth"}),t==="top"?history.replaceState(null,null," "):history.pushState(null,null,`#${t}`)})})</script><script>var mybutton=document.getElementById("top-link");window.onscroll=function(){document.body.scrollTop>800||document.documentElement.scrollTop>800?(mybutton.style.visibility="visible",mybutton.style.opacity="1"):(mybutton.style.visibility="hidden",mybutton.style.opacity="0")}</script><script>document.getElementById("theme-toggle").addEventListener("click",()=>{document.body.className.includes("dark")?(document.body.classList.remove("dark"),localStorage.setItem("pref-theme","light")):(document.body.classList.add("dark"),localStorage.setItem("pref-theme","dark"))})</script><script>document.querySelectorAll("pre > code").forEach(e=>{const n=e.parentNode.parentNode,t=document.createElement("button");t.classList.add("copy-code"),t.innerHTML="copy";function s(){t.innerHTML="copied!",setTimeout(()=>{t.innerHTML="copy"},2e3)}t.addEventListener("click",t=>{if("clipboard"in navigator){navigator.clipboard.writeText(e.textContent),s();return}const n=document.createRange();n.selectNodeContents(e);const o=window.getSelection();o.removeAllRanges(),o.addRange(n);try{document.execCommand("copy"),s()}catch{}o.removeRange(n)}),n.classList.contains("highlight")?n.appendChild(t):n.parentNode.firstChild==n||(e.parentNode.parentNode.parentNode.parentNode.parentNode.nodeName=="TABLE"?e.parentNode.parentNode.parentNode.parentNode.parentNode.appendChild(t):e.parentNode.appendChild(t))})</script></body></html>